Omiganan

N/A

Report date: 2024/11/18 20:00:28
NME

Base Information

Drug NameOmiganan
Drug Alias NameOmigananum奥米加南Omiganan pentahydrochlorideOmiganan pentahydrochloride 1% gelOmiganan pentachloride +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsRosaceaDermatitis, SeborrheicAcne Vulgaris +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[10] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCarrus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCadence PharmaceuticalsBiowest Therapeutics IncMaruho Co Ltd
Active IndicationsN/A
Inactive IndicationsRosaceaDermatitis, SeborrheicAcne Vulgaris +[10] 

Other Information

ATC CodeN/A
Related LinksKEGG